Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice

Journal of Endocrinology

Volumn 189, Issue 3, 2006, Pages 617-627

  Svensson, Johan ^c   Diez, M ^a   Engel, J ^b   Wass, C ^b   Tivesten, A ^c   Jansson, J O ^c   Isaksson, O ^c   Archer, T ^b   Hokfelt T ^a   Ohlsson, C ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DYNORPHIN; ENKEPHALIN; MESSENGER RNA; METABOTROPIC RECEPTOR 7; SOMATOMEDIN C;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; HIPPOCAMPUS; HORMONE SYNTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LEARNING; LIVER; MAZE TEST; MEMORY; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYNAPSE; TASK PERFORMANCE;

AGING; ALZHEIMER DISEASE; ANIMALS; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR I; LIVER; MAZE LEARNING; MEMORY; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; POLY I-C;

EID: 33745269576     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06631     Document Type: Article

References (69)

1. Aberg M, Aberg N, Hedbacker H, Oscarsson J & Eriksson P 2000 Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. Journal of Neuroscience 20 2896-2903.
2. Abuzzahab M, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D et al. 2003 IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. New England Journal of Medicine 349 2211-2222.
3. Adams J 1992 Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. Journal of Histochemistry and Cytochemistry 40 1457-1463.
4. Amaducci L & Tesco G 1994 Aging as a major risk for neurodegenerative diseases of the central nervous system. Current Opinion in Neurology 7 283-286.
5. Araujo D, Lapchak P, Collier B, Chabot J & Quirion R 1989 Insulin-like growth factor-I (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Research 484 130-138.
6. Archer T, Palomo T & Fredriksson A 2002 Functional deficits following neonatal dopamine depletion and isolation housing: circular water maze acquisition under pre-exposure conditions and motor activity. Neurotoxicity Research 4 503-522.
7. Bengtsson B-Å, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L & Isaksson O 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 76 309-317.
8. Bleich S, Romer K, Wiltfang J & Kornhuber J 2003 Glutamate and the glutamate receptor system: a target for drug action. International Journal of Geriatric Psychiatry 18 (Suppl 1) S33-S40.
9. Bondy C, Werner H, Roberts CJ & LeRoith D 1992 Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the brain: comparison with insulin-like growth factors I and II. Neuroscience 46 909-923.
10. Busiguina S, Fernandez A, Barrios V, Clark R, Tolbert D, Berciano J & Torres-Aleman I 2000 Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiology of Disease 7 657-665.
11. Carro E, Nunez A, Busiguina S & Torres-Aleman I 2000 Circulating insulin-like growth factor I mediates effects of exercise on the brain. Journal of Neuroscience 20 2926-2933.
12. Carro E, Trejo J, Busiguina S & Torres-Aleman I 2001 Circulating insulin-like growth factor-I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. Journal of Neuroscience 21 5678-5684.
13. Carro E, Trejo J, Gomez-Isla T, LeRoith D & Torres-Aleman I 2002 Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nature Medicine 8 1390-1397.
14. Carson M, Behringer R, Brinster R & McMorris F 1993 Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10 729-740.
15. Civelli O, Douglas J, Goldstein A & Herbert E 1985 Sequence and expression of the rat prodynorphin gene. PNAS 82 4291-4295.
16. Cole T, Wenzel H, Kafer K, Schwartzkroin P & Palmiter R 1999 Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. PNAS 96 1716-1721.
17. Dagerlind Å, Friberg K, Bean A & Hökfelt T 1992 Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98 39-49.
18. Dentremont K, Ye P, D'Ercole A & O'Kusky J 1999 Increased insulin-like growth factor-I (IGF-I) expression during early postnatal development differentially increases neuron number and growth in medullary nuclei of the mouse. Brain Research, Developmental Brain Research 12 135-141.
19. D'Ercole A & O'Kusky J 2002 Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 38 209-220.
20. Diez M, Koistinaho J, Kahn K, Games D & Hökfelt T 2000 Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein - initial observations. Neuroscience 100 259-286.
21. Diez M, Danner S, Frey P, Sommer B, Staufenbiel S, Wiederhold K-H & Hökfelt T 2003 Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing APP with the Swedish double mutation (APP23). Neurobiology of Disease 14 579-594.
22. Dik M, Pluijm S, Jonker C, Deeg D, Lomecky M & Lips P 2003 Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiology of Aging 24 573-581.
23. Ehrnborg C, Lange K, Dall R, Christiansen J, Lundberg P, Baxter R, Boroujerdi M, Bengtsson B, Healey M, Pentecost C et al. 2003 The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. Journal of Clinical Endocrinology and Metabolism 88 394-401.
24. Fredriksson A, Schröder N, Eriksson P, Izquierdo I & Archer T 2000 Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Research. Developmental Brain Research 119 65-74.
25. Fredriksson A, Archer T, Alm H, Gordh T & Eriksson P 2004 Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behavioural Brain Research 153 367-376.
26. Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L, White CL & Araoz C 1989 Brain interleukin 1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. PNAS 86 7611-7615.
27. Herbison A, Simonian S, Norris P & Emson P 1996 Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat. Journal of Neuroendocrinology 8 73-82.
28. Holzenberger M, Hamard G, Zaoui R, Leneuve P, Ducos B, Beccavin C, Perin L & Le Bouc Y 2001 Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. Endocrinology 142 4469-4478.
29. Kaklamani V, Linos A, Kaklamani E, Markaki I, Koumataki Y & Mantzoros C 1999 Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. Journal of Clinical Oncology 17 3291-3298.
30. Kar S, Seto D, Dore S, Hanisch U & Quirion R 1997 Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. PNAS 94 14054-14059.
31. Kuhn R, Schwenk F, Aguet M & Rajewsky K 1995 Inducible gene targeting in mice. Science 269 1427-1429.
32. Kurawski G, Benedik M, Kamb B, Abrams J, Zurawski S & Lee F 1986 Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science 232 772-775.
33. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosén T, Lindstedt G, Lundberg P-A & Bengtsson B-Å 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology 41 351-357.
34. Lee H, Dunwiddie T & Hoffer B 1980 Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. II. Effects of interneuron excitability. Brain Research 184 331-342.
35. Liu J, Grinberg A, Westphal H, Sauer B, Accili D, Karas M & LeRoith D 1998 Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Molecular Endocrinology 12 1452-1462.
36. Markowska A, Mooney M & Sonntag W 1998 Insulin-like growth factor-I ameliorates age-related behavioral deficits. Neuroscience 87 559-569.
37. Morris R 1981 Spatial localization does not require the presence of local cues. Learning and Motivation 12 239-260.
38. Morris R, Garrud P, Rawlins J & O'Keefe J 1982 Place navigation impaired in rats with hippocampal lesions. Nature 297 681-683.
39. Niikura T, Hashimoto Y, Okamoto T, Abe Y, Yasukawa T, Kawasumi M, Hiraki T, Kita Y, Terashita K, Kouyama K et al. 2001 Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V6421 mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. Journal of Neuroscience 21 1902-1910.
40. Nilsson L, Sara V & Nordberg A 1988 Insulin-like growth factor I stimulates the release of acetylcholine from rat cortical slices. Neuroscience Letters 88 221-226.
41. O'Hooge R & De Deyn P 2001 Applications of the Morris water maze in the study of learning and memory. Brain Research. Brain Research Reviews 36 60-90.
42. O'Kusky J, Ye P & D'Ercole A 2000 Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. Journal of Neuroscience 20 8435-8442.
43. Palmiter R, Cole T, Quaife C & Findley S 1996 ZnT-3, a putative transporter of zinc into synaptic vesicles. PNAS 93 14934-14939.
44. Reinhardt R & Bondy C 1994 Insulin-like growth factors cross the blood-brain barrier. Endocrinology 135 1753-1761.
45. Saito T, Takahashi K, Nakagawa N, Hosokawa T, Kurasaki M, Yamanoshita O, Yamamoto Y, Sasaki H, Nagashima K & Fujita H 2000 Deficiencies of hippocampal Zn and ZnT3 accelerate brain aging of rat. Biochemical and Biophysical Research Communications 279 505-511.
46. Schultzberg M, Hökfelt T, Terenius L, Elfvin, L Lundberg J, Brandt J, Elde R & Goldstein M 1979. Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience 4 249-270.
47. Segal M 1977 Morphine and enkephalin interactions with putative neurotransmittors in rat hippocampus. Neuropharmacology 16 587-592.
48. Selkoe D 2002 Alzheimer's disease is a synaptic failure. Science 298 789-791.
49. Shigemoto R, Kulik A, Roberts J, Ohishi H, Nusser Z, Kaneko T & Somogyi P 1996 Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature 381 523-525.
50. Sjögren K, Liu J, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Törnell J, Isaksson OG, Jansson JO et al. 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principle source of IGF-I in blood but is not required for postnatal body growth in mice. PNAS 96 7088-7092.
51. Sjögren K, Wallenius K, Liu J, Bohlooly YM, Pacini G, Svensson L, Törnell J, Isaksson OG, Ahren B, Jansson JO et al. 2001 Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50 1539-1545.
52. Sjögren K, Sheng M, Moverare S, Liu J, Wallenius K, Törnell J, Isaksson OG, Jansson JO, Mohan S & Ohlsson C 2002 Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. Journal of Bone and Mineral Research 17 1977-1987.
53. Sonntag W, Lynch C, Thornton P, Khan A, Bennett S & Ingram R 2000 The effects of growth hormone and IGF-I deficiency on cerebrovascular and brain ageing. Journal of Anatomy 197 575-585.
54. Sonntag W, Carter C, Ikeno Y, Ekenstedt K, Carlson C, Loeser R, Chakrabarty S, Lee S, Bennett C, Ingram R et al. 2005 Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146 2920-2932.
55. Sundström E, Archer T, Melander T & Hökfelt T 1988 Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neuroscience Letters 88 331-335.
56. Tivesten Å, Bollano E, Andersson I, Fitzgerald S, Caidahl K, Sjögren K, Skott O, Liu J, Mobini R, Isaksson OG et al. 2002 Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143 4235-4242.
57. Trejo J, Carro E & Torres-Aleman I 2001 Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. Journal of Neuroscience 21 1628-1634.
58. Trejo J, Carro E, Lopez-Lopez C & Torres-Aleman I 2004 Role of serum insulin-like growth factor I in mammalian brain aging. Growth Hormone and IGF Research 14 (Suppl A) S39-S43.
59. Unger J 1998 Glial reaction in aging and Alzheimer's disease. Microscopy Research and Technique 43 24-28.
60. van Dam P, de Winter C, de Vries R, van der Grond J, Drent M, Lijffijt M, Kenemans J, Aleman A, de Haan E & Koppeschaar H 2005 Childhood-onset growth hormone deficiency, cognitive function and brain N-acetylaspartate. Psychoneuroendocrinology 30 357-363.
61. Verhofstad A, Steinbusch H, Joosten H, Penke B, Varga J & Goldstein M 1983 Immunocytochemical localization of noradrenaline, adrenaline and serotonin. In Immunocytochemistry: Practical Applications in Pathology and Biology, pp 143-168. Eds JM Polak & S Van Norden. Bristol: Wright.
62. Vicario-Abejon C, Yusta-Boyo M, Fernandez-Moreno C & de Pablo F 2003 Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. Journal of Neuroscience 23 895-906.
63. Wagner J, Terman G & Chavkin C 1993 Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 363 451-454.
64. Wallenius K, Sjögren K, Peng X, Park S, Wallenius V, Liu J, Umaerus M, Wennbo H, Isaksson OG, Frohman L et al. 2001 Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142 4762-4770.
65. Weber E, Evans C & Barchas J 1982a Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions. Nature 299 77-79.
66. Weber E, Roth K & Barchas J 1982b Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization. PNAS 79 3062-3066.
67. Weisskopf M, Zalutsky R & Nicoll R 1993 The opiod peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362 423-427.
68. Woods K, Camacho-Hübner C, Savage M & Clark A 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine 335 1363-1367.
69. Yakar S, Liu J, Stannard B, Butler A, Accili D, Sauer B & LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. PNAS 96 7324-7329.